Real-world evidence shows Pfizer-BioNTech vaccine effective in kids, adolescents

Real-world evidence published Tuesday in MMWR demonstrated that the Pfizer-BioNTech vaccine has protected children and adolescents against COVID-19, including kids aged 5 to 11 years.
The study by Nicola P. Klein, MD, a senior research scientist for Kaiser Permanente, and colleagues, analyzed nearly 40,000 ED and urgent care (UC) visits and 1,700 hospitalizations among children aged 5 to 17 years who received the vaccine between April 9 and Jan. 29 in 10 states. The researchers estimated vaccine effectiveness using a case-control test-negative design.
Vaccine effectiveness against

Real-world evidence published Tuesday in MMWR demonstrated that the Pfizer-BioNTech vaccine has protected children and adolescents against COVID-19, including kids aged 5 to 11 years.
The study by Nicola P. Klein, MD, a senior research scientist for Kaiser Permanente, and colleagues, analyzed nearly 40,000 ED and urgent care (UC) visits and 1,700 hospitalizations among children aged 5 to 17 years who received the vaccine between April 9 and Jan. 29 in 10 states. The researchers estimated vaccine effectiveness using a case-control test-negative design.
Vaccine effectiveness against